The five-year survival rate of early stage liver cancer patients is about 70%~80% after surgical resection and other treatments. Hepatocellular carcinoma is one of the common malignant tumors, and the occurrence of the disease is related to gene mutation, hepatitis virus infection, liver cirrhosis and other factors. Early-stage patients usually have limited lesions, and after radical surgical resection, a good cure rate can often be achieved, with a five-year survival rate of about 70%~80%, and the prognosis is often not measured by the number of years. After surgery, radiotherapy can be supplemented according to the condition in order to achieve a better therapeutic effect. Chemotherapy drugs include gemcitabine, albumin paclitaxel, etc., which should be used under medical advice. Patients should pay attention to regular review after surgery, maintain good habits in daily life, and exercise appropriately in order to improve the treatment rate and prolong the survival period.